Kyobo 8 Special Purpose Acquisition Company (307280) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kyobo 8 Special Purpose Acquisition Company (307280) has a cash flow conversion efficiency ratio of 0.063x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.66 Billion ≈ $1.80 Million USD) by net assets (₩41.96 Billion ≈ $28.44 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View Kyobo 8 Special Purpose Acquisition Comp share price for real-time trading data and today's change.
Kyobo 8 Special Purpose Acquisition Company - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how Kyobo 8 Special Purpose Acquisition Company's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see 307280 company net worth for the company's overall valuation and market capitalisation.
Kyobo 8 Special Purpose Acquisition Company Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kyobo 8 Special Purpose Acquisition Company ranked by their cash flow conversion efficiency. Also see 307280 total asset value for a full breakdown of the balance sheet.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Texxon Holding Ltd.
NASDAQ:NPT
|
N/A |
|
Crown Crafts Inc
NASDAQ:CRWS
|
0.137x |
|
RMG Acquisition Corp. III
NASDAQ:RMGCF
|
0.034x |
|
5TH PLANET GAMES DK -50
F:2HG1
|
-0.027x |
|
Colorpak Indonesia Tbk
JK:CLPI
|
0.041x |
|
Live Ventures Inc
NASDAQ:LIVE
|
0.103x |
|
Hotel Fitra International Tbk PT
JK:FITT
|
-0.096x |
|
Atlas Pearls Ltd
AU:ATP
|
-0.048x |
Annual Cash Flow Conversion Efficiency for Kyobo 8 Special Purpose Acquisition Company (2022–2025)
The table below shows the annual cash flow conversion efficiency of Kyobo 8 Special Purpose Acquisition Company from 2022 to 2025. Review 307280 free cash flow debt coverage to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩42.62 Billion ≈ $28.89 Million |
₩8.48 Billion ≈ $5.75 Million |
0.199x | -16.18% |
| 2024-12-31 | ₩37.27 Billion ≈ $25.26 Million |
₩8.85 Billion ≈ $6.00 Million |
0.237x | +60.22% |
| 2023-12-31 | ₩32.62 Billion ≈ $22.11 Million |
₩4.84 Billion ≈ $3.28 Million |
0.148x | -31.24% |
| 2022-12-31 | ₩26.83 Billion ≈ $18.18 Million |
₩5.78 Billion ≈ $3.92 Million |
0.216x | -- |
About Kyobo 8 Special Purpose Acquisition Company
Wonbiogen Co., Ltd. manufactures and sells wound dressings in South Korea, rest of Asia, Europe, and internationally. It operates through Wound Dressing and Daily Necessities divisions. The company offers polyurethane foam and hydrocolloid dressings; cosmetics; other dressings; and daily necessities. It also provides medical, organic, and inorganic materials; and laundry detergents. Wonbiogen Co.… Read more